INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
586 sh
May 7, 2026May 11, 2026
Page 835 of 1737
← PrevNext →
traded May 7, 2026
+4d
SEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
960 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
1,163 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
946 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
682 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$182K
945 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$110K
541 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
586 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
HC
Hogan Thomas ChristopherEVP/CLO & Corp Secretary
CINFCINCINNATI FINANCIAL CORP
Tax withholding
F$23K
145 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
4,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
BR
Bazarko Anthony R.Chief Commercial Officer
SEERSeer, Inc.
Grant or award
A—
225.0K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
1,199 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
TE
Terry Anthony EDirector
NWLNEWELL BRANDS INC.
Option exercise
M—
30.4K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
RR
Rosenthal RobertPresident, Udemy Business
UDMYUdemy, Inc.
Disposition to issuer
D—
485.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SA
Sartori AlessandroArtistic Director
ZGNErmenegildo Zegna N.V.
Option exercise
M—
31.5K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SO
Suarez OscarDirector
AMTBAmerant Bancorp Inc.
Option exercise
M—
3,761 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
RG
Robb Andrew GeorgeDirector
DIBS1stdibs.com, Inc.
Grant or award
A—
26.8K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,600 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,600 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
NR
Niebergall RossDirector
VVXV2X, Inc.
Option exercise
M—
838 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
25.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
TE
Taylor EveretteDirector
DIBS1stdibs.com, Inc.
Grant or award
A—
26.8K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
HC
Hogan Thomas ChristopherEVP/CLO & Corp Secretary
CINFCINCINNATI FINANCIAL CORP
Tax withholding
F$12K
74 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SA
Swithenbank AuroraEVP, Chief Financial Officer
NMIHNMI Holdings, Inc.
Tax withholding
F—
2,922 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
GA
Gray James AndyChief Compliance/Risk Officer
ACICAMERICAN COASTAL INSURANCE Corp
Tax withholding
F$33K
3,042 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,499 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
TE
Terry Anthony EDirector
NWLNEWELL BRANDS INC.
Grant or award
A—
39.3K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
HH
Hiles HeatherDirector
UDMYUdemy, Inc.
Disposition to issuer
D—
100.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
VP
Volent PaulaDirector
DIBS1stdibs.com, Inc.
Grant or award
A—
26.8K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
LW
Lo Renee WonlaiDirector
IARTINTEGRA LIFESCIENCES HOLDINGS CORP
Grant or award
A—
17.7K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,200 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
HA
Holder AlisonChief Brand & Product Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$13K
3,692 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
BN
Bell NicholasDirector
NCMINational CineMedia, Inc.
Grant or award
A—
32.3K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,401 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
HC
Hogan Thomas ChristopherEVP/CLO & Corp Secretary
CINFCINCINNATI FINANCIAL CORP
Option exercise
M$34K
487 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
YS
Yiu Kin Wah StephenDirector
ASAmer Sports, Inc.
Option exercise
M—
7,265 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
RA
Rucker AshakiDirector
AMTBAmerant Bancorp Inc.
Option exercise
M—
3,761 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
82 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence